Befejeződött1. fázis
A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis
Key facts
- Where
- Bialystok, Bydgoszcz, Nadarzyn és Poznan, LengyelországSee the 7 sites
- Phase
- 1. fázis
Where in Lengyelország
- Nova Reuma Domyslawska I Rusilowicz Lekarza Reumatologa I Fizjoterapeuty sp.p.Bialystok, LengyelországNo longer taking part
- Medicover Integrated Clinical Services Sp. z o.o.Bydgoszcz, LengyelországNo longer taking part
- NZOZ Lecznica MAK MED S CNadarzyn, LengyelországNo longer taking part
- Med Polonia Sp z o.o.Poznan, LengyelországNo longer taking part
- Medyczne Centrum Hetmańska Piotr LeszczyńskiPoznan, LengyelországNo longer taking part
- Prywatna Praktyka Lekarska Prof. Dr HabMed Pawel HrycajPoznan, LengyelországNo longer taking part
- Reumedika Sp. z o.o.Poznan, LengyelországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- IGM Biosciences Inc.
- Trial code
- EU 2023-505127-31-00
- Record updated
- 2024. október 28.